Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Association between COVID-19 and exacerbation of allergic skin diseases. Local targets link to admitted publications; unresolved targets remain external evidence.
Covid-19.
10.7326/aitc202310170 · 2023 · External reference
The Global Network COVID-19 studies: a review.
10.1111/1471-0528.17610 · 2023 · External reference
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
10.1111/bjd.19163 · 2020 · External reference
Cutaneous manifestations of COVID-19: an evidence-based review.
10.1007/s40257-020-00558-4 · 2020 · External reference
Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
10.1111/bjd.19264 · 2020 · External reference
COVID-19 and dermatology: a comprehensive guide for dermatologists.
10.1111/jdv.16545 · 2020 · External reference
Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.
10.1016/j.jaci.2021.01.006 · 2021 · External reference
The risk of COVID-19 infection in patients with atopic dermatitis: a retrospective cohort study.
10.1016/j.jaad.2021.09.061 · 2022 · External reference
Allergic diseases aggravate the symptoms of SARS-CoV-2 infection in China.
10.3389/fimmu.2023.1284047 · 2023 · External reference
SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.
10.1111/bjd.20435 · 2021 · External reference
Atopic dermatitis is not associated with SARS-CoV-2 outcomes.
10.1007/s00403-021-02276-1 · 2022 · External reference
Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional study.
10.1111/bjd.20062 · 2021 · External reference
Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019.
10.1016/j.anai.2020.07.012 · 2020 · External reference
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria.
10.1111/all.14687 · 2021 · External reference
Bidirectional Mendelian randomization analysis did not indicate a causal relationship between atopic dermatitis and COVID-19.
10.1093/bjd/ljad208 · 2023 · External reference
Recent developments in the immunopathology of COVID-19.
10.1111/all.15593 · 2023 · External reference
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis.
10.1111/jdv.16411 · 2020 · External reference
Rates of SARS-CoV-2 infection in paediatric patients with atopic dermatitis or asthma in Brooklyn, New York.
10.1111/apa.16203 · 2022 · External reference
Incidence of asthma, atopic dermatitis, and allergic rhinitis in Korean adults before and during the COVID-19 pandemic using data from the Korea National Health and Nutrition Examination Survey.
10.3390/ijerph192114274 · 2022 · External reference
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: results of the UCARE COVAC-CU study.
10.1016/j.jaci.2023.07.019 · 2023 · External reference
The impact of COVID-19 pandemic on the management of patients with chronic urticaria: an observational two-center study from Turkey.
10.1111/dth.14652 · 2021 · External reference
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – a position paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).
10.5414/alx02241e · 2021 · External reference
The effect of SARS-CoV-2 virus infection on the course of atopic dermatitis in patients.
10.3390/medicina57060521 · 2021 · External reference
COVID-19-associated disease course is shortened in moderate-to-severe atopic dermatitis patients receiving dupilumab treatment: a retrospective cross-sectional study.
10.3390/jcm12103415 · 2023 · External reference
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?
10.2500/aap.2021.42.210087 · 2021 · External reference
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
10.1016/s0140-6736(22)00327-0 · 2022 · External reference
Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions.”.
10.1016/j.jaci.2019.01.003 · 2019 · External reference
Atopic dermatitis.
10.1016/s0140-6736(20)31286-1 · 2020 · External reference
Atopic dermatitis.
10.1016/s0140-6736(15)00149-x · 2016 · External reference
Chronic urticaria and atopic disorders: a cross-sectional study of 11 271 patients.
10.1111/bjd.15347 · 2017 · External reference
Characterization of chronic urticaria and associated conditions in a large population of adolescents.
10.1016/j.jaad.2019.02.034 · 2019 · External reference
Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
10.1542/peds.2005-0969 · 2005 · External reference
Atopic dermatitis is not associated with SARS-CoV-2 outcomes.
10.1007/s00403-021-02276-1 · ExternalCitation · doi-reference
Cutaneous manifestations of COVID-19: an evidence-based review.
10.1007/s40257-020-00558-4 · ExternalCitation · doi-reference
Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019.
10.1016/j.anai.2020.07.012 · ExternalCitation · doi-reference
Characterization of chronic urticaria and associated conditions in a large population of adolescents.
10.1016/j.jaad.2019.02.034 · ExternalCitation · doi-reference
The risk of COVID-19 infection in patients with atopic dermatitis: a retrospective cohort study.
10.1016/j.jaad.2021.09.061 · ExternalCitation · doi-reference
Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions.”.
10.1016/j.jaci.2019.01.003 · ExternalCitation · doi-reference
Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.
10.1016/j.jaci.2021.01.006 · ExternalCitation · doi-reference
Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: results of the UCARE COVAC-CU study.
10.1016/j.jaci.2023.07.019 · ExternalCitation · doi-reference
Atopic dermatitis.
10.1016/s0140-6736(15)00149-x · ExternalCitation · doi-reference
Atopic dermatitis.
10.1016/s0140-6736(20)31286-1 · ExternalCitation · doi-reference
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
10.1016/s0140-6736(22)00327-0 · ExternalCitation · doi-reference
Bidirectional Mendelian randomization analysis did not indicate a causal relationship between atopic dermatitis and COVID-19.
10.1093/bjd/ljad208 · ExternalCitation · doi-reference
The Global Network COVID-19 studies: a review.
10.1111/1471-0528.17610 · ExternalCitation · doi-reference
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria.
10.1111/all.14687 · ExternalCitation · doi-reference
Recent developments in the immunopathology of COVID-19.
10.1111/all.15593 · ExternalCitation · doi-reference
Rates of SARS-CoV-2 infection in paediatric patients with atopic dermatitis or asthma in Brooklyn, New York.
10.1111/apa.16203 · ExternalCitation · doi-reference
Chronic urticaria and atopic disorders: a cross-sectional study of 11 271 patients.
10.1111/bjd.15347 · ExternalCitation · doi-reference
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
10.1111/bjd.19163 · ExternalCitation · doi-reference
Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
10.1111/bjd.19264 · ExternalCitation · doi-reference
Risk of COVID-19 infection in adult patients with atopic eczema and psoriasis: a single-centre cross-sectional study.
10.1111/bjd.20062 · ExternalCitation · doi-reference
SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.
10.1111/bjd.20435 · ExternalCitation · doi-reference
The impact of COVID-19 pandemic on the management of patients with chronic urticaria: an observational two-center study from Turkey.
10.1111/dth.14652 · ExternalCitation · doi-reference
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis.
10.1111/jdv.16411 · ExternalCitation · doi-reference
COVID-19 and dermatology: a comprehensive guide for dermatologists.
10.1111/jdv.16545 · ExternalCitation · doi-reference
Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
10.1542/peds.2005-0969 · ExternalCitation · doi-reference
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?
10.2500/aap.2021.42.210087 · ExternalCitation · doi-reference
Allergic diseases aggravate the symptoms of SARS-CoV-2 infection in China.
10.3389/fimmu.2023.1284047 · ExternalCitation · doi-reference
Incidence of asthma, atopic dermatitis, and allergic rhinitis in Korean adults before and during the COVID-19 pandemic using data from the Korea National Health and Nutrition Examination Survey.
10.3390/ijerph192114274 · ExternalCitation · doi-reference
COVID-19-associated disease course is shortened in moderate-to-severe atopic dermatitis patients receiving dupilumab treatment: a retrospective cross-sectional study.
10.3390/jcm12103415 · ExternalCitation · doi-reference
The effect of SARS-CoV-2 virus infection on the course of atopic dermatitis in patients.
10.3390/medicina57060521 · ExternalCitation · doi-reference
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – a position paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).
10.5414/alx02241e · ExternalCitation · doi-reference
Covid-19.
10.7326/aitc202310170 · ExternalCitation · doi-reference
